Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 27 - Issue 3 - March, 2015

Department

Letters to the Editor
Is the Evaluation Sufficient? Interpretation on the Cardiac Inhomogeneity Without Considering the Transmural Dispersion
02/24/2015

Omer Yiginer, MD1;  Abdullah Haholu, MD2;  Mehmet Tezcan, MD3;  Namik Ozmen, MD1

Omer Yiginer, MD1;  Abdullah Haholu, ...
The authors opine on a previous study by Mirbolouk et al (J Invasive Cardiol. 2014;26(9):444-450) and recommend the addition of transmural dispersion data to the study to reveal the effects of revascularization procedures on electrical...
The authors opine on a previous study by Mirbolouk et al (J Invasive Cardiol. 2014;26(9):444-450) and recommend the addition of transmural dispersion data to the study to reveal the effects of revascularization procedures on electrical...
The authors opine on a previous...
02/24/2015
Journal of Invasive Cardiology

Column

Invasive Thoughts
Interventional Cardiology: Reflections on My Career Choice at 10 Years
02/24/2015

Srihari S. Naidu, MD 

Srihari S. Naidu, MD 
Dr Naidu offers his thoughts on the state of Interventional Cardiology after a decade in practice.
Dr Naidu offers his thoughts on the state of Interventional Cardiology after a decade in practice.
Dr Naidu offers his thoughts on...
02/24/2015
Journal of Invasive Cardiology
Intravascular-Ultrasound Assisted Localization and Revascularization of an Ostial Chronic Total Occlusion: Utility of Near-Field and Far-Field Imaging
02/24/2015

Eric L. Wallace, DO and Khaled M. Ziada, MD

Eric L. Wallace, DO and Khaled M. Zia...
We demonstrate the utility of intravascular ultrasound imaging in the localization of an ambiguous or “stump-less” ostial CTO in addition to providing real-time far-field imaging, which is helpful in tracking wire progress through the...
We demonstrate the utility of intravascular ultrasound imaging in the localization of an ambiguous or “stump-less” ostial CTO in addition to providing real-time far-field imaging, which is helpful in tracking wire progress through the...
We demonstrate the utility of...
02/24/2015
Journal of Invasive Cardiology
Percutaneous Transcatheter Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis in a patient With Orthotopic Heart Transplant
02/24/2015

Gaurav Rana, MBBS;  Jeffrey Shih, MD;  Nikolaos Kakouros, MBBS, MRCP, PhD

Gaurav Rana, MBBS;  Jeffrey Shih, MD;...
A 47-year-old man with history of familial cardiomyopathy and orthotopic heart transplant at the age of 34 years presented severe tricuspid stenosis (TS) with a mean transvalvular gradient of 10 mm Hg. To the best of our knowledge, this is...
A 47-year-old man with history of familial cardiomyopathy and orthotopic heart transplant at the age of 34 years presented severe tricuspid stenosis (TS) with a mean transvalvular gradient of 10 mm Hg. To the best of our knowledge, this is...
A 47-year-old man with history...
02/24/2015
Journal of Invasive Cardiology

Feature

Original Contribution
Adoption of the Hybrid CTO Approach by a Single Non-CTO Operator: Procedural and Clinical Outcomes
02/24/2015

Minh N. Vo, MD1;  James M. McCabe, MD2;  William L. Lombardi, MD2;  John Ducas, MD1; Amir Ravandi, MD, PhD1;  Emmanouil S. Brilakis, MD, PhD3

Minh N. Vo, MD1;  James M. McCabe, MD...
This study tested the feasibility of adopting the “hybrid” approach by a single operator without prior experience in CTO-PCI. The authors conclude that the “hybrid” approach to CTO-PCI can be successfully adopted by a single operator with...
This study tested the feasibility of adopting the “hybrid” approach by a single operator without prior experience in CTO-PCI. The authors conclude that the “hybrid” approach to CTO-PCI can be successfully adopted by a single operator with...
This study tested the...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
Clinical and Economic Effectiveness of Percutaneous Ventricular Assist Devices for High-Risk Patients Undergoing Percutaneous Coronary Intervention
02/24/2015

Atman P. Shah, MD1;  Elizabeth M. Retzer, MD1;  Sandeep Nathan, MD, MSc1;  Jonathan D. Paul, MD1; Janet Friant, MSN1;  Karin E. Dill, MD2;  Joseph L. Thomas, MD3

Atman P. Shah, MD1;  Elizabeth M. Ret...
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).
This study conducted a review of...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
Safety, Feasibility, and Long-Term Results of Percutaneous Closure of Atrial Septal Defects Using the Amplatzer Septal Occluder Without Periprocedural Echocardiography
02/24/2015

Fabien Praz, MD;  Andreas Wahl, MD;  Mathieu Schmutz, MD;  Jean-Pierre Pfammatter, MD;  Mladen Pavlovic, MD; St√©phanie Perruchoud, MD;  Andrea Remondino, MD;  Stephan Windecker, MD;  Bernhard Meier, MD

Fabien Praz, MD;  Andreas Wahl, MD;  ...
Percutaneous closure of atrial septal defects (ASDs) is usually performed using simultaneous fluoroscopic and transthoracic, transesophageal, or intracardiac echocardiographic guidance. This study sought to assess the safety and efficacy of...
Percutaneous closure of atrial septal defects (ASDs) is usually performed using simultaneous fluoroscopic and transthoracic, transesophageal, or intracardiac echocardiographic guidance. This study sought to assess the safety and efficacy of...
Percutaneous closure of atrial...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
Comparison of Diabetic and Non-Diabetic Patients Undergoing Endovascular Revascularization for Peripheral Arterial Disease
02/24/2015

Michael S. Lee, MD1;  Seung-Woon Rha, MD, PhD2*;  Seung Kyu Han, MD3;  Byoung Geol Choi, BS2;  Se Yeon Choi, BS2;  Jabar Ali, MD2;  Shaopeng Xu, MD2;  Harris Abdullah Ngow, MD2;  Jae Joong Lee, MD2;  Kwang No Lee, MD2;  Ji Bak Kim, MD2;  Sunki Lee, MD2;  Jin Oh Na, MD2;  Cheol Ung Choi, MD2; Hong Euy Lim, MD2;  Jin Won Kim, MD2;  Eung Ju Kim, MD2;  Chang Gyu Park, MD2;  Hong Seog Seo, MD2;  Jeremy Kong, BS¬π;  Dong Joo Oh, MD2

Michael S. Lee, MD1;  Seung-Woon Rha,...
This study assessed the clinical outcomes of diabetic versus non-diabetic patients with peripheral arterial disease who underwent peripheral transluminal angioplasty (PTA). Diabetic patients were found to more frequently present with critical...
This study assessed the clinical outcomes of diabetic versus non-diabetic patients with peripheral arterial disease who underwent peripheral transluminal angioplasty (PTA). Diabetic patients were found to more frequently present with critical...
This study assessed the clinical...
02/24/2015
Journal of Invasive Cardiology
Original Contribution
A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients
02/24/2015

James B. Hermiller, MD1;  Wayne Leimbach, MD2;  Roger Gammon, MD3;  Steven P. Karas, MD4; Robert J. Whitbourn, MD5;  S. Chiu Wong, MD6;  Nilesh Goswami, MD7;  John McCabe, MD8;  Nick G. Cavros, MD9;  Richard Paulus, MD10;  Srihari S. Naidu, MD11;  Zoltan G. Turi, MD12

James B. Hermiller, MD1;  Wayne Leimb...
The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...
The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...
The RESPECT trial was a...
02/24/2015
Journal of Invasive Cardiology

Insights

Commentary
Commentary: Intraaortic Balloon Pump Versus Percutaneous Ventricular Assist for the High-Risk Patient: Keep it Simple Except When You Can`t
02/24/2015

Mary Shields, MD and Sheldon Goldberg, MD 

Mary Shields, MD and Sheldon Goldberg...
In order to put the pVAD analysis of Shah et al into clinical perspective, Drs Shields and Goldberg review the definitions of “high-risk PCI,” the mechanism of action of support devices for PCI patients, and comment on the results of trials...
In order to put the pVAD analysis of Shah et al into clinical perspective, Drs Shields and Goldberg review the definitions of “high-risk PCI,” the mechanism of action of support devices for PCI patients, and comment on the results of trials...
In order to put the pVAD...
02/24/2015
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

March 2015 Volume 27 Issue 3

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement